Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)
Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –
Ironwood Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
Ironwood Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2020 was 99.2%. For fiscal 2020 it was 99.2%, against 94.4% the year before. The highest annual figure on record is 100.0% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | 99.2% | +4.8 |
| FY2019 | Dec 31, 2019 | 94.4% | +3.9 |
| FY2018 | Dec 31, 2018 | 90.6% | −3.0 |
| FY2017 | Dec 31, 2017 | 93.6% | −5.7 |
| FY2016 | Dec 31, 2016 | 99.3% | −0.7 |
| FY2015 | Dec 31, 2015 | 100.0% | +6.9 |
| FY2014 | Dec 31, 2014 | 93.1% | +24.6 |
| FY2013 | Dec 31, 2013 | 68.5% | −30.8 |
| FY2012 | Dec 31, 2012 | 99.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | 99.2% | +8.0 |
| Q3 FY2020 | Sep 30, 2020 | 100.0% | +0.4 |
| Q2 FY2020 | Jun 30, 2020 | 100.0% | +11.1 |
| Q1 FY2020 | Mar 31, 2020 | 97.2% | −1.3 |
| Q4 FY2019 | Dec 31, 2019 | 91.3% | +7.7 |
| Q3 FY2019 | Sep 30, 2019 | 99.6% | +6.6 |
| Q2 FY2019 | Jun 30, 2019 | 88.9% | −6.1 |
| Q1 FY2019 | Mar 31, 2019 | 98.5% | +2.3 |
| Q4 FY2018 | Dec 31, 2018 | 83.6% | −6.9 |
| Q3 FY2018 | Sep 30, 2018 | 93.0% | −0.0 |
| Q2 FY2018 | Jun 30, 2018 | 95.0% | +0.4 |
| Q1 FY2018 | Mar 31, 2018 | 96.2% | −2.8 |
| Q4 FY2017 | Dec 31, 2017 | 90.5% | – |
| Q3 FY2017 | Sep 30, 2017 | 93.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 94.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 99.0% | – |
See a number that looks wrong?